Study Group: Nephrologists (US)(?)
Council Members in this Study Group: 525
Request a survey with this Study Group
Leading Experts in this Study Group
Steven Fishbane, MDChief of Nephrology, Medical Director
Winthrop-University Hospital Inc
Steven Fishbane, MD, is Professor of Medicine at the State University of New York at Stony Brook School of Medicine. Additionally, Dr. Fishbane serves as Chief of Nephrology, Associate Chairman of the Department of Medicine, and Director of End-Stage Renal Disease Research at Winthrop-University Hospital...
Chief, Division of Nephrology
Stanford University School of Medicine
Glenn Chertow, MD, MPH, is Professor of Medicine and Chief, Division of Nephrology, at Stanford University School of Medicine and Director of Nephrology Services at Stanford Hospital and Clinics. His research interests are focused on epidemiology, health services research, and clinical trials in acute...
Richard Amerling, MDDirector of Outpatient Dialysis
BETH ISRAEL MEDICAL CENTER INC
Richard Amerling, MD, is Director of Outpatient Dialysis and Continuous Renal Replacement Therapy at the Beth Israel Medical Center in New York City, since June 1990. Dr. Amerling has an extensive background in all aspects of consultative nephrology including hypertension, kidney stones, glomerular...
Medical Director
Davita Los Angeles Dialysis Center
Jack Rubin, MD, is Medical Director of the Los Angeles Vascular Access Center (LAVAC) in Inglewood, California. LAVAC does out patient procedures to correct problems with vascular accesses in dialysis patients. LAVAC also does out-patient angiograms of the legs and repairs stenoses of femoral arteries...
Medical Director
The Rogosin Institute Inc
Jeffrey Silberzweig, MD, is Medical Director of The Rogosin Institute's Manhattan Dialysis Center and the New York Presbyterian Hospital's Inpatient Dialysis Unit as well as the Co-Director of The Rogosin Institute Queens Dialysis Center. He is also a faculty member at Cornell University Medical College....
Clinical Associate Professor
Michigan State University
Andrew Krutul, MD, is a Nephrologist at the Renal Associates of western Michigan in Grand Rapids Michigan. He served for years as a Clinical Section Chief of Nephrology at St Mary's Mercy Medical Center and serves as a Clinical Associate Professor at the Michigan State University School of Medicine....
Partner
Nephrology Associates of Montgomery County
Jeffrey Perlmutter, MD, is a Nephrologist in private practice in Maryland. He has experience in the treatment of all forms of acute and chronic kidney disease including the care of patients with end stage renal disease requiring dialysis or transplantation. He is the Medical Director of a hospital-based...
Medical Director
Dva Renal Healthcare, Inc.
Edward Littman, MD, is the Medical Director of the Davita Dialysis Clinics in Norwalk, Connecticut. He also serves as a Clinical Associate Professor of Medicine at the Yale University School of Medicine. Dr. Littman’s major area of expertise is in dialysis treatment of chronic kidney disease. He was...
Related Study Groups
GLG NewsSMAnalyses by this Study Group's Leading Experts(?)
Over the past 15 years there have been several long-term trials which have provided evidence that reduction of systolic pressure in an elderly population prevents the cognitive decline associated with ageing. The most recent studies have demonstrated the prevention of Alzheimer's-like symptoms. These...
Considering the effects of fosamax and other bisphosphonates on bone remodeling, it is not at all surprising to see problems arising with the long term use of these agents.
Bisphosphonates, including medications like Fosamax, prevents normal bone turnover and metabolism. Nephrologists had anticipated similar findings as these recent reports as over-suppression of normal bone turnover may be associated with adynamic bone disease and possibly fractures. The process...
It's intresting that nowhere in this article was the topic of true insurance for catastrophic illness brought up. The problem with our current health insurance market is that for most it is pre-paid care, not insurance against a rare, but catastrophic, event.
With the pipeline for new drugs running dry, it is no surprise that pharmaceutical companies are looking to expand indications for existing products still under patent protection. What better way to do this than by creating entirely new patient populations out of whole cloth?
Most Common Company Types:
- Academic Medical Center/Hospital or Clinic
- Office Based Private Practice or Clinic
- Non-Academic Community Hospital or Clinic
- Academic Institution*
- Other Freestanding Healthcare Facility
Most Common Job Types:
- Physician - Attending Physician
- Physician - Director
- Owner
- Physician - Division Head
- Director
- Medical Director
GLG's 750+ Clients Include:
global mutual funds
global banks
private equity firms

